UnitedHealth Eyes Retreat From Latin America After $8.3 Billion Loss

UnitedHealth Group Inc (NYSE:UNH) is reportedly weighing multiple offers for its Latin American business as it scrambles to recover from a string of corporate stumbles, including a leadership shakeup and a reported federal investigation.The potential sale, involving its Banmedica unit, comes as the company seeks to restore shareholder confidence and streamline operations under new leadership.In May, UnitedHealth's CEO, Andrew Witty, resigned for personal reasons. Stephen Hemsley, who previously held the CEO title from 2006 to 2017, succeeded him. The company also suspended its 2025 outlook.Also Read: UnitedHealth Hits 2008-Era Oversold Levels As Citadel Advisors Sells, Fisher BuysIn an SEC filing on Wednesday, UnitedHealth said it canceled the performance-based restricted stock units granted to Witty,Year to date, UnitedHealth's stock has plunged almost 40%, with the majority coming after ...Full story available on Benzinga.comWeiter zum vollständigen Artikel bei Benzinga Weiter zum vollständigen Artikel bei Benzinga